Video

Dr. Gomella on Screening in Prostate Cancer

Leonard Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, encourages early screening for prostate cancer.

Leonard Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, encourages early screening for prostate cancer.

The current status of screening for prostate cancer is at a very low level. Only recently have the National Comprehensive Cancer Network guidelines begun to recommend which patients should undergo genetic testing for inherited prostate cancer risk.

Gomella advises that patients not only include prostate, breast, and ovarian cancers, but also melanoma, pancreatic cancer, Lynch syndrome, gastrointestinal tract tumors, and upper tract urothelial tumors in their family history forms. These may all be related to inherited risk for prostate cancer, says Gomella.

Though the exact number of men who have inherited prostate cancer risk is unknown, it is very high. It’s important to identify those men who have increased risk of developing prostate cancer because early screening may be advantageous to these individuals.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD